Adventist Health System West’s Vanguard Intermediate-Term Corporate Bond ETF VCIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,308
Closed -$853K 13
2026
Q1
$853K Buy
+10,308
New +$862K 0.15% 10

Other funds holding VCIT

Adventist Health System West's VCIT Position: Q2 2026 in Review

Adventist Health System West sold out of Vanguard Intermediate-Term Corporate Bond ETF (VCIT) in Q2 2026, closing a stake of 10,308 shares — an estimated $853K sold.

Adventist Health System West first reported a position in VCIT in Q1 2026 and held it in 1 quarter. The position peaked at $853K in Q1 2026. 1,360 funds tracked by Wall St. Rank hold VCIT as of Q2 2026.

  • Adventist Health System West reported no remaining Vanguard Intermediate-Term Corporate Bond ETF position as of Q2 2026 after selling out during the quarter.
  • Adventist Health System West sold 10,308 Vanguard Intermediate-Term Corporate Bond ETF shares in Q2 2026, an estimated $853K.
  • Adventist Health System West first reported a position in Vanguard Intermediate-Term Corporate Bond ETF in Q1 2026 and held it in 1 quarter.
  • Adventist Health System West's Vanguard Intermediate-Term Corporate Bond ETF position peaked at $853K in Q1 2026.
  • 1,360 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Corporate Bond ETF as of Q2 2026.

Based on Adventist Health System West's 13F filing for Q2 2026, filed 14 Aug 2026.